View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Guy Sips ... (+4)
  • Guy Sips
  • Jacob Mekhael
  • Livio Luyten
  • Wim Hoste
Jacob Mekhael
  • Jacob Mekhael

MaaT Pharma Model update post € 9.1m capital raise

MaaT announced the completion of a capital raise of € 9.1m (at a 9% discount to closing price prior to deal announcement), and expects to use the net proceeds of € 8.7m to fund Xervyteg commercialisation preparation in Europe, advance MaaT033 development, and prepare for a pivotal US study of Xervyteg in 2026. This capital raise unlocks a € 6m EIB tranche, extending the company's cash runway to August 2026. Upon anticipated EU approval of Xervyteg in mid-2026, MaaT is eligible to receive a € 12m...

 PRESS RELEASE

Syensqo - Acquisition of own shares

Syensqo - Acquisition of own shares Regulated information Acquisition of own shares  Brussels, November 17, 2025 - 17:45 CET In accordance with article 7:215 of the Belgian Code of Companies and Associations, Syensqo SA (“Syensqo” or the “Company”) pursues its Share Buyback Program (or the “Program”) announced on September 30, 2024, covering up to €300 million. The fourth tranche began on July 31, 2025 and will cover a maximum amount of up to €50 million (of the €300 million Program). The Company intends to cancel all shares acquired through this tranche.  In the framework...

Mathijs Geerts Danau
  • Mathijs Geerts Danau

MaaT Pharma Launches capital increase for gross proceeds of € 9m &#x07...

MaaT announced the launch of a capital increase through a private placement with qualified investors and retail investors. The company intends to raise € 9m, the funds will extend the runway to summer 2026 (previously February 2026). MaaT plans to use the proceeds to fund the company's development and commercialization of Xervyteg. Trading will be suspended until at least November 14 after market close. We view this raise as a positive and reiterate our BUY rating and € 17 TP.

Hilde Van Boxstael ... (+4)
  • Hilde Van Boxstael
  • Lynn Hautekeete
  • Mathijs Geerts Danau
  • Wim Lewi
 PRESS RELEASE

Syensqo exercises the first call option to redeem €500 million hybrid ...

Syensqo exercises the first call option to redeem €500 million hybrid Bonds Communiqué de presse Persbericht Regulated Syensqo exercises the first call option to redeem €500 million hybrid Bonds Brussels, November 14, 2025 - 8:30am CET Syensqo SA (the “Issuer”) today announces its decision to exercise its first call option on the €500 million Undated Deeply Subordinated Fixed-to-Reset Rate Perpetual NC5.5 Bonds (ISIN: BE6324000858), following notification to the Agent, the National Bank of Belgium, and the Luxembourg Stock Exchange, where the bonds are listed. This perpetual deepl...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

AEGON: 3Q in line, UK weak, all eyes on CMD in December. DEME Group: Going into 2026 with a stable order book. D'Ieteren: North America Beron peer Boyd confirms positive l/l in 3Q25, further improvement in 4Q25. KBC: 3Q above, increase in FY25 guidance across the board, first SRT is sizeable. Ontex: Peer Essity acquires Edgewell's Feminine Care activity. SBM Offshore: Progression in markets and earnings. Zabka: CVC and PG sell 100m shares via ABB

Guy Sips ... (+7)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Mathijs Geerts Danau
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi

Morning Notes : AGN NA, AGFB BB, IVA FP, MDXH BB, MELE BB, SOLB BB, DE...

: AGN NA, AGFB BB, IVA FP, MDXH BB, MELE BB, SOLB BB, DEME BB, AUTL US, ZEAL DC, PHVS US

Guy Sips
  • Guy Sips

DEME Although 3Q was weaker y/y another record year is taking shape

As 3Q25 turnover was € 980.9m (-9% y/y also impacted by a strong comparison base), 9M25 turnover surpassed €3bn, still a 3% y/y increase. Although y/y all segments had lower revenues in 3Q (-6% for Dredging & Intra, -12.7% for Offshore Energy, -16.3% for Environmental), DEME indicated that the YtD performance is fuelled by a double-digit YtD growth in the Offshore Energy segment which more than offset softer topline results in other segments compared to strong prior year revenues. Given this 9...

Thijs Berkelder
  • Thijs Berkelder
 PRESS RELEASE

Trading update Q3 2025: another record year taking shape

Trading update Q3 2025: another record year taking shape Highlights third quarter 2025 Group nine-month turnover surpassed 3 billion euros, a 3% increase year-over-yearOrder book is 7.5 billion euros, compared to 7.1 billion euros last yearManagement reiterates its expectations that full-year turnover will be at least in line with 2024 and forecasts a strong year-over-year EBITDA improvement, with the EBITDA margin in the range of 20% to 22%DEME took delivery of its new offshore installation vessel Norse Wind in October, completed on schedule, and set to commence operations in the first ha...

 PRESS RELEASE

Trading update Q3 2025: een nieuw recordjaar krijgt vorm

Trading update Q3 2025: een nieuw recordjaar krijgt vorm Hoogtepunten derde kwartaal 2025 De groepsomzet over negen maanden overschreed 3 miljard euro, een stijging met 3% jaar over jaarHet orderboek bedroeg 7,5 miljard euro, tegenover 7,1 miljard euro vorig jaarHet management bevestigt opnieuw zijn verwachting dat de omzet voor het volledige jaar minstens in lijn zal liggen met 2024 en verwacht een sterke verbetering van de EBITDA, met de EBITDA-marge in de range van 20% tot 22%DEME’s nieuwe offshore installatieschip Norse Wind werd volgens planning in oktober opgeleverd, en zal in de eer...

UCB SA: 1 director

A director at UCB SA bought 200 shares at 216.000EUR and the significance rating of the trade was 54/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing ...

 PRESS RELEASE

Syensqo - Acquisition of own shares

Syensqo - Acquisition of own shares Regulated information Acquisition of own shares  Brussels, November 10, 2025 - 17:45 CET In accordance with article 7:215 of the Belgian Code of Companies and Associations, Syensqo SA (“Syensqo” or the “Company”) pursues its Share Buyback Program (or the “Program”) announced on September 30, 2024, covering up to €300 million. The fourth tranche began on July 31, 2025 and will cover a maximum amount of up to €50 million (of the €300 million Program). The Company intends to cancel all shares acquired through this tranche.  In the framework of t...

Thijs Berkelder
  • Thijs Berkelder

DEME Group : Playing chess on multiple tables, it’s all about the next...

Benefitting from an almost perfect project delivery in offshore wind, especially in the US, DEME in our view should be able to improve its 2025 EBITDA to a new record level of € 881m (= 21% margin). Although its orderbook for 2026 in H1 still was screening weaker than a year ago, the early delivery and contracting of the high margin Havfram vessels (€ 900m acquisition) makes us confident that DEME also in 2026 should be able to exceed the € 800m EBITDA level. As such, we today upgrading to Outp...

Hilde Van Boxstael ... (+7)
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Livio Luyten
  • Michiel Declercq
  • Thomas Couvreur
  • Wim Hoste
  • Wim Lewi
Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch